Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD
Metabolic reprogramming is a key feature of Autosomal Dominant Polycystic Kidney Disease (ADPKD) characterized by changes in cellular pathways occurring in response to the pathological cell conditions. In ADPKD, a broad range of dysregulated pathways have been found. The studies supporting alteratio...
Guardado en:
Autores principales: | Roberto Pagliarini, Christine Podrini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae76745dd9a24741b189a4bd188d2ce9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease
por: ZHANG,TONG, et al.
Publicado: (2009) -
Agent Clustering Strategy Based on Metabolic Flux Distribution and Transcriptome Expression for Novel Drug Development
por: Yao Ruan, et al.
Publicado: (2021) -
Intrusive Dislocation in Permanent Teeth: Review of Literature and Clinical Case Report
por: Braga,Renata de Almeida, et al.
Publicado: (2019) -
Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Joana M. O. Santos, et al.
Publicado: (2021) -
The Impact of COVID-19 on Patients With ADPKD
por: Meherzad Kutky, et al.
Publicado: (2021)